Equasens SA
PAR:EQS
Intrinsic Value
Equasens engages in the development of management software packages for drugstores. [ Read More ]
The intrinsic value of one EQS stock under the Base Case scenario is 66.21 EUR. Compared to the current market price of 55.7 EUR, Equasens SA is Undervalued by 16%.
Valuation Backtest
Equasens SA
Run backtest to discover the historical profit from buying and selling EQS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Equasens SA
Current Assets | 132.3m |
Cash & Short-Term Investments | 54.7m |
Receivables | 67.3m |
Other Current Assets | 10.3m |
Non-Current Assets | 261.8m |
Long-Term Investments | 95.1m |
PP&E | 32.9m |
Intangibles | 130.3m |
Other Non-Current Assets | 3.5m |
Current Liabilities | 108.1m |
Accounts Payable | 16.1m |
Other Current Liabilities | 92m |
Non-Current Liabilities | 66.6m |
Long-Term Debt | 44.7m |
Other Non-Current Liabilities | 22m |
Earnings Waterfall
Equasens SA
Revenue
|
219.8m
EUR
|
Cost of Revenue
|
-69.1m
EUR
|
Gross Profit
|
150.6m
EUR
|
Operating Expenses
|
-95.4m
EUR
|
Operating Income
|
55.2m
EUR
|
Other Expenses
|
-8.2m
EUR
|
Net Income
|
47m
EUR
|
Free Cash Flow Analysis
Equasens SA
EQS Profitability Score
Profitability Due Diligence
Equasens SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Equasens SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
EQS Solvency Score
Solvency Due Diligence
Equasens SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Equasens SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EQS Price Targets Summary
Equasens SA
According to Wall Street analysts, the average 1-year price target for EQS is 88.4 EUR with a low forecast of 75.75 EUR and a high forecast of 110.25 EUR.
Shareholder Return
EQS Price
Equasens SA
Average Annual Return | 15.55% |
Standard Deviation of Annual Returns | 47.55% |
Max Drawdown | -61% |
Market Capitalization | 837.2m EUR |
Shares Outstanding | 15 033 256 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the development and integration of management software packages for drugstores. The company offers all IT (Information Technology) and High-Tech fields related to Health and in specialized fields which are associated to it such as IT for pharmacies, solutions for e-Health, solutions for pharmaceutical industry, solutions for patients etc. The firm operates in four divisions that includes Europe Pharmacy Solutions Division including France Pharmacy Section and Belgium and Luxembourg Pharmacy Section, Solutions for sanitary and medico-social entities Division, e-Health Solutions Division including e-Laboratories section, e-Patients section and e-Connect section and Fintech Division.
Contact
IPO
Employees
Officers
The intrinsic value of one EQS stock under the Base Case scenario is 66.21 EUR.
Compared to the current market price of 55.7 EUR, Equasens SA is Undervalued by 16%.